Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Massachusetts General Hospital · University of Alabama at Birmingham · +36 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
272
total citations
- FWCI
- 29.21
- Percentile
- 100%
- References
- 42
Citations per year
Authors
84Topics & keywords
Topics
Keywords
- Neurofibromatosis
- Medicine
- Nomenclature
- Neurofibromatosis type 2
- Delphi method
- Neurofibromatoses
- Genetic testing
- Pathology
No related works found for this paper.
Funding
- UDU.S. Department of Defense
- CTChildren's Tumor Foundation
- AAstraZeneca
- SSanofi
- APAlexion Pharmaceuticals
- RPRegeneron Pharmaceuticals
- PBPuma Biotechnology
- STSpringworks Therapeutics
- NINational Institute for Health and Care ResearchAwards: BRC-1215-20007, IS-BRC-1215, IS-BRC-1215-20007
- NINational Institutes of HealthAward: IS-BRC-1215-20007
- MBManchester Biomedical Research CentreAwards: IS-BRC-1215-20007, BRC-1215-20007, 20007, IS-BRC-1215